Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.394,17
-0,78%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Synthetic Biologics Inc (SYN) Synthetic Biologics Inc (SYN) Notizie

SYN

Synthetic Biologics (SYN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:SYN
DataOraFonteTitoloSimboloCompagnia
27/06/202323:11Edgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
08/06/202313:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
11/05/202314:17Edgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
30/03/202314:18Edgar (US Regulatory)Annual Report (10-k)AMEX:SYNSynthetic Biologics Inc
09/12/202212:04Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:SYNSynthetic Biologics Inc
05/12/202222:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:SYNSynthetic Biologics Inc
29/09/202213:25TipRanksMaxim Group Sticks to Its Buy Rating for Synthetic Biologics (SYN)AMEX:SYNSynthetic Biologics Inc
16/09/202222:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:SYNSynthetic Biologics Inc
06/09/202222:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:SYNSynthetic Biologics Inc
16/08/202223:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:SYNSynthetic Biologics Inc
11/08/202215:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:SYNSynthetic Biologics Inc
04/08/202212:03Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:SYNSynthetic Biologics Inc
17/05/202217:45TipRanksMaxim Group Thinks Synthetic Biologics’ Stock is Going to RecoverAMEX:SYNSynthetic Biologics Inc
23/02/202222:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:SYNSynthetic Biologics Inc
09/02/202213:15PR Newswire (US)Synthetic Biologics to Present at 2022 BIO CEO & Investor ConferenceAMEX:SYNSynthetic Biologics Inc
08/02/202213:15PR Newswire (US)Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDAAMEX:SYNSynthetic Biologics Inc
26/01/202222:05PR Newswire (US)Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022AMEX:SYNSynthetic Biologics Inc
14/12/202113:00PR Newswire (US)Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid TumorsAMEX:SYNSynthetic Biologics Inc
03/11/202121:10PR Newswire (US)Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ETAMEX:SYNSynthetic Biologics Inc
26/10/202113:00PR Newswire (US)Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021AMEX:SYNSynthetic Biologics Inc
22/10/202123:01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:SYNSynthetic Biologics Inc
21/10/202113:00PR Newswire (US)Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline PhosphataseAMEX:SYNSynthetic Biologics Inc
06/10/202122:36PR Newswire (US)Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of QuorumAMEX:SYNSynthetic Biologics Inc
21/09/202122:30PR Newswire (US)Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of QuorumAMEX:SYNSynthetic Biologics Inc
25/08/202122:31Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)AMEX:SYNSynthetic Biologics Inc
05/08/202122:10PR Newswire (US)Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ETAMEX:SYNSynthetic Biologics Inc
03/08/202123:23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:SYNSynthetic Biologics Inc
03/08/202113:00PR Newswire (US)Synthetic Biologics Expands Option for an Exclusive License Agreement with Massachusetts General HospitalAMEX:SYNSynthetic Biologics Inc
28/07/202113:00PR Newswire (US)Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021AMEX:SYNSynthetic Biologics Inc
29/06/202113:00PR Newswire (US)Synthetic Biologics Provides Update on SYN-020 Intestinal Alkaline Phosphatase Phase 1 Single-Ascending Dose Clinical TrialAMEX:SYNSynthetic Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:SYN

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network